I'm a 30yr smoker - but quit 2yrs ago Yay
In clinical trials, the combination injectable Soliqua has demonstrated effective sugar control, without weight gain and with lower risk of hypoglycemia, compared to twice daily premix insulins. Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal insulin and lixisenatide, a GLP-1 receptor agonist
Paraoxonase Activity and Genetic Polymorphisms in Northern Han Chinese Workers Exposed to Organophosphate Pesticides. Experimental Biology and Medicine (Maywood, N.J.), vol
The specific amount of weight you might lose from Zepbound is uncertain, but significant weight loss ranging from 35.5 lb (16.1 kg) to 52.0 lb (23.6 kg) was observed in the 72-week SURMOUNT-1 clinical trial, which compared different Zepbound (tirzepatide) doses to a placebo (inactive treatment)
GLP-1 helps control hunger and how the body uses food
[PMID: 2185038] PubMed record related to this compound for laboratory literature review